NYSE · MET
Financial Services · Insurance - Life
$100.02
Down-$0.81 (-0.80%)
Updated Nov 1, 2026, 12:32 PM
SID Score
8.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance · MET
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
MET closed at $100.02 after 20 trading sessions, up 3.24% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $101.60 | $101.665 | $99.695 | $100.02 | 4.03M |
| Oct 29, 2026 | $101.00 | $101.88 | $100.48 | $100.83 | 2.96M |
| Oct 28, 2026 | $100.00 | $100.73 | $99.145 | $99.64 | 2.39M |
| Oct 27, 2026 | $100.36 | $100.489 | $99.41 | $99.98 | 1.92M |
| Oct 26, 2026 | $99.46 | $100.815 | $99.40 | $100.04 | 3.07M |
| Oct 23, 2026 | $102.52 | $103.18 | $97.66 | $98.82 | 5.99M |
| Oct 22, 2026 | $101.59 | $103.65 | $101.21 | $103.57 | 3.51M |
| Oct 21, 2026 | $101.86 | $102.57 | $101.60 | $102.18 | 3.05M |
| Oct 20, 2026 | $99.98 | $101.39 | $99.824 | $101.18 | 2.1M |
| Oct 19, 2026 | $100.25 | $101.0899 | $99.53 | $99.58 | 2.03M |
| Oct 16, 2026 | $101.00 | $102.425 | $100.64 | $100.76 | 3.36M |
| Oct 15, 2026 | $100.24 | $100.62 | $98.62 | $100.27 | 3.04M |
| Oct 14, 2026 | $99.79 | $99.905 | $98.38 | $99.72 | 3.7M |
| Oct 13, 2026 | $101.01 | $101.44 | $99.90 | $100.65 | 3.02M |
| Oct 12, 2026 | $98.97 | $100.18 | $98.8825 | $100.17 | 2.37M |
| Oct 9, 2026 | $98.10 | $99.00 | $96.73 | $98.33 | 2.34M |
| Oct 8, 2026 | $95.82 | $98.75 | $95.705 | $98.47 | 3.02M |
| Oct 7, 2026 | $96.34 | $96.82 | $95.42 | $95.78 | 3.18M |
| Oct 6, 2026 | $97.19 | $99.06 | $97.00 | $97.16 | 4.3M |
| Oct 5, 2026 | $94.84 | $97.39 | $94.655 | $96.88 | 4.42M |
The latest Smart Investors Daily articles mentioning MET.
Company
Market Activity
Research & News
MET research
Company profile and research snapshot.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 21, 2026 | TD Cowen | Buy | — |
| Oct 15, 2026 | JP Morgan | Overweight | — |
| Oct 12, 2026 | Wells Fargo | Overweight | — |
| Oct 7, 2026 | Barclays | Overweight | — |
| Oct 7, 2026 | Mizuho | Outperform | — |
No generated briefing is available yet.
ChartMill · Oct 31, 2026
MetLife (MET) earns a 10/10 technical rating and 8/10 setup score, trading near 52-week highs with a constructive, risk-defined breakout entry and stop.
Yahoo · Oct 30, 2026
Evaluate the expected performance of MetLife (MET) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Yahoo · Oct 29, 2026
Hippo Holdings (HIPO) delivered earnings and revenue surprises of +54.17% and +0.87%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Yahoo · Oct 28, 2026
MetLife has delivered a strong long run for shareholders over the past few years, which naturally puts the focus on whether that price performance is backed by the returns the insurer earns on its capital. With the stock now changing hands close to US$100, the key issue for investors is how that market value lines up with what the business is actually generating on the capital it employs. Over the last 5 years the share price has gained 82.5%, which raises a clear question about whether the...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MET.
